Study to determine the antioxidant potency of Seresis® in the serum of healthy volunteers and the optimal time for blood sampling
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Changes in total antioxidant activity of Seresis®
determined by chemoluminescence
Time frame: Baseline, Day 2
Changes in total antioxidant activity of Seresis®
determined by chemoluminescence
Time frame: Day 2, day 6
Assessment of tolerability on a 4-point scale
Time frame: Day 14
Number of patients with abnormal changes in laboratory parameters
Time frame: up to day 14
Number of patients with adverse events
Time frame: up to day 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.